{"guidelines": [{"category": "", "code": "", "description": "The diagnosis and management of AL amyloidosis\r\n", "title": "AL amyloidosis", "url": "http://www.bcshguidelines.com/documents/Amyloid_2014.pdf", "date": "2014"}, {"category": "", "code": "", "description": "", "title": "Prophylactic Anti-D immunoglobin", "url": "http://www.bcshguidelines.com/documents/BCSH_Anti_D_guidelines_-__Amendment_4_8_14_(2).pdf", "date": "2014"}, {"category": "", "code": "", "description": "This guideline is updated from 2010 version.  In 2013 changes were made in section 2.4 (pages 7-8), and levels of evidence converted to GRADE system.  A further addendum was made in 2014 to section 7.1.2 (page 22) and section 9.4 (pages 35-36).  References for these sections have been updated to 2014.", "title": "Multiple myeloma", "url": "http://www.bcshguidelines.com/documents/MYELOMA_GUIDELINE_Feb_2014_for_BCSH.pdf", "date": "2014"}, {"category": "", "code": "", "description": "This guideline is an updated version of the 2011 guideline.  ", "title": "T-cell, leukaemias", "url": "http://www.bcshguidelines.com/documents/T_NHL_guideline_3_8_13_updated_with_changes_accepted_v1_rg.pdf", "date": "2013"}, {"category": "", "code": "", "description": "This addendum is in relation to patients receiving T-cell depleting agents such as alemtuzumab for non-haematological indications including solid organ transplantation, multiple sclerosis and vasculitis.", "title": "Irradiated blood", "url": "http://www.bcshguidelines.com/documents/BCSH_TTF_addendum_irradiation_guidelines_final_6_11_12.pdf", "date": "2012"}, {"category": "", "code": "", "description": "", "title": "Blood Components", "url": "http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdf", "date": "2012"}, {"category": "", "code": "", "description": "The BCSH pdf version is more extensive than the published version.", "title": "ATR", "url": "http://www.bcshguidelines.com/documents/ATR_final_version.pdf", "date": "2012"}, {"category": "", "code": "", "description": "", "title": "Hereditary spherocytosis", "url": "http://www.bcshguidelines.com/documents/HS_BCSH_Sept_2011_final.pdf", "date": "2011"}, {"category": "", "code": "", "description": "", "title": "Iron Deficiency", "url": "http://www.bcshguidelines.com/documents/UK_Guidelines_iron_deficiency_in_pregnancy.pdf", "date": "2011"}, {"category": "", "code": "", "description": "", "title": "Iron Deficiency", "url": "http://www.bcshguidelines.com/documents/UK_Guidelines_iron_deficiency_in_pregnancy.pdf", "date": "2011"}, {"category": "", "code": "", "description": "This is an addendum to THE 2009 guidelines on the management of aplastic anaemia.", "title": "Aplastic anaemia", "url": "http://www.bcshguidelines.com/documents/Use_of_rabbit_ATG_July_2011.pdf", "date": "2011"}, {"category": "", "code": "", "description": "Please note changes to previous version: Appendix 5 and 9 have minor additions referencing testing to the URS.  Appendix 8 has a change in wording to PQ.  Appendix 10 has an extra column in the table to reference the test script to the URS/FDS.  Please see also the full guideline.", "title": "Validation and qualification", "url": "http://www.bcshguidelines.com/documents/TTF_Appendices_to_Guidelines_for_Validation_Hospital_and_Lab.pdf", "date": "2010"}, {"category": "", "code": "", "description": "An update of the 2008 BCSH guideline incorporating the 2008 WHO guidelines as they apply to lymphoproliferative disorder.", "title": "Lymphoma", "url": "http://www.bcshguidelines.com/documents/Lymphoma_diagnosis_bcsh_042010.pdf", "date": "2010"}, {"category": "", "code": "", "description": "Please also see the guideline on best practice in lymphoma diagnosis and reporting.\r\n\r\nThis guideline is an update to the 2008 BCSH guideline incorporating the 2008 WHO guidelines as they apply to lymphoproliferative disorders", "title": "Lymphoma", "url": "http://www.bcshguidelines.com/documents/Lymphoma_disease_app_bcsh_042010.pdf", "date": "2010"}, {"category": "", "code": "", "description": "", "title": "Levels of Care", "url": "http://www.bcshguidelines.com/documents/levelsofcare_042010.pdf", "date": "2010"}, {"category": "", "code": "", "description": "", "title": "Blood components", "url": "http://www.bcshguidelines.com/documents/Admin_blood_components_bcsh_05012010.pdf", "date": "2009"}, {"category": "", "code": "", "description": "Please see the full FMH guideline, 2009.", "title": "FMH, fetomaternal haemorrhage", "url": "http://www.bcshguidelines.com/documents/BCSH_FMH_summary_sept2009.pdf", "date": "2009"}, {"category": "", "code": "", "description": "This is an updated version of the guideline published in February 2009.  Please see the summary of amendments.", "title": "FMH, fetomaternal haemorrhage", "url": "http://www.bcshguidelines.com/documents/BCSH_FMH_bcsh_sept2009.pdf", "date": "2009"}, {"category": "", "code": "", "description": "", "title": "Plasmacytomas; solitary of bone, multiple solitary and extramedullary", "url": "http://www.bcshguidelines.com/documents/solitary_plamacytoma_bcsh_FINAL_190109.pdf", "date": "2009"}, {"category": "", "code": "", "description": "Please see the 2004 guidelines for the use of fresh-frozen plasma, cryoprecipitate and cyrosupernatant and also the 2005 amendment to these guidelines.", "title": "Fresh-frozen plasma, cryopreciperate and cryosupernatant", "url": "http://www.bcshguidelines.com/documents/FFPAmendment_2_17_Oct_2007.pdf", "date": "2007"}, {"category": "", "code": "", "description": "", "title": "INR", "url": "http://www.bcshguidelines.com/documents/INR_in_Patients_not_on_Vitamin_K_Antagonists_2007.pdf", "date": "2007"}, {"category": "", "code": "", "description": "Please see 2004 transfusion guidelines for neonates and older children and also the 2005 amendment to these guidelines.", "title": "Neonates and older children", "url": "http://www.bcshguidelines.com/documents/FFP_neonate_Amendment_1_17_Oct_2007.pdf", "date": "2007"}, {"category": "", "code": "", "description": "", "title": "Blood grouping and antibody testing in pregnancy", "url": "http://www.bcshguidelines.com/documents/antibody_testing_pregnancy_bcsh_07062006.pdf", "date": "2006"}, {"category": "", "code": "", "description": "", "title": "IT, Information Technology", "url": "http://www.bcshguidelines.com/documents/IT_blood_testing_22052006.pdf", "date": "2006"}, {"category": "", "code": "", "description": "Please see the 2004 guidelines on transfusion for neonates and older children and also the 2007 amendment.", "title": "Neonates and older children, paediatric", "url": "http://www.bcshguidelines.com/documents/transfusion_neonates_amendments_bcsh__091205.pdf", "date": "2005"}, {"category": "", "code": "", "description": "Please see the 2004 guidelines for the use of fresh frozen plasma, cryoprecipitate, and cryosupernatant and also the 2007 amendment.", "title": "FFP, fresh frozen plasma, cryoprecipitate and cryosupernatant", "url": "http://www.bcshguidelines.com/documents/FFP_Amendments__09122005.pdf", "date": "2005"}], "categories": []}